Capricor Therapeutics Inc (NASDAQ:CAPR)
| 5.50 Delayed Data As of Sep 22 |  +0.05 / +0.92%Today’s Change | 3.30 Today|||52-Week Range 8.22 | +42.49% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Avat Xavier |  Sale | 4/05/2023 | 70,019 | $4.19 | $293.4K | +31.26% |
Avat Xavier |  Buy | 4/05/2023 | 84,791 | $3.46 | $293.4K | +31.26% |
Avat Xavier | Sale | 4/17/2023 | 14,772 | $4.29 | $63.4K | +28.21% |
Litvack Frank Director | Sale | 8/14/2023 | 4,364 | $6.61 | $28.8K | -16.79% |
Marban Linda /linda/ Chief Executive Officer | Buy | 5/12/2023 | 20,749 | $1.39 | $28.8K | +36.48% |
Litvack Frank Director | Buy | 8/14/2023 | 20,748 | $1.39 | $28.8K | -16.79% |
Litvack Frank Director | Sale | 2/21/2023 | 4,524 | $4.31 | $19.5K | +27.61% |
Litvack Frank Director | Buy | 2/21/2023 | 14,027 | $1.39 | $19.5K | +27.61% |
Avat Xavier | Sale | 3/28/2023 | 3,000 | $4.06 | $12.2K | +34.15% |
Manzo Louis Director | Sale | 2/21/2023 | 452 | $4.31 | $1.9K | +27.61% |
Page of 2